Tudorza PressairActive Ingredient(s): Aclidinium Bromide
FDA Approved: * July 23, 2012
Pharm Company: * FOREST LABS INC
Category: Lungs (Pulmonary)
Aclidinium bromide (INN) is a long-acting, inhaled muscarinic antagonist (LAMA) approved in the United States on July 24, 2012 as a maintenance treatment for chronic obstructive pulmonary disease (COPD). Evidence shows that it can improve quality of life and prevent hospitalization in those with COPD. However, it does not appear to affect the risk of death or the frequency steroids are needed. It is unclear if it diff... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
I am looking for a coupon or discount to offset the amount that my health insurance does not cover ## As far as saving m...1 REPLY
Is anyone on the new inhaler Tudorza and a new drug for copd called Daliresp and have you had any problem s with either ...3 REPLIES
Is tudorza pressair covered by bcbsil, what is co pay?...
difficult breathing in to turn the indicator red...